Merck Tops On Q3 Earnings, Patent Expiries Hit Revenues
October 27, 2014 at 16:08 PM EDT
Merck & Co. reported third quarter 2014 earnings of 90 cents per share, beating the Zacks Consensus Estimate of 88 cents. Earnings, however, declined 2.2% from the year-ago period.
